Stock ATLN ACTELION
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Actelion Share Price

Equities

ATLN

CH0010532478

Biotechnology & Medical Research

Chart Actelion

Dynamic Chart

Latest news about Actelion

Actelion : France's Sanofi raises earnings forecast, pleased with eczema drug uptake RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast RE
Johnson & Johnson : J&J sees sales growth in near-term; raises 2017 profit forecast RE
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16 RE
Actelion : Johnson & Johnson expects to complete Actelion purchase on June 16 RE
Actelion : Johnson & Johnson expects to complete of Actelion offer on June 16 RE
Akzo Nobel : Cross-border M&A between U.S. and European firms at 10 year high RE
Actelion : Johnson & Johnson offers EU concessions over Actelion deal RE
Actelion : Johnson & Johnson target Actelion could exit Swiss benchmark SMI index this month RE
Actelion : Johnson & Johnson first quarter revenue misses estimates; new forecast includes Actelion RE
Actelion : shareholders back R&D spinoff, keep J&J deal on track RE
Actelion : J&J declares Actelion tender offer a success, sees closing in second quarter RE
Genmab A/S : and J&J's cancer drug set for blockbuster sales this year RE
Bristol Myers Squibb : Icahn buys Bristol-Myers shares, adding to activist pressure RE
Actelion : How Sanofi lost out to J&J in $30 billion battle for Actelion RE
More news

Analyst Recommendations on Actelion

Dollar's post-Fed rally pauses, U.S. stocks end lower RE
Actelion : raises guidance for third time this year on strong PAH sales RE
More recommendations

Press releases Actelion

Actelion : Pharmaceuticals US, Inc, - Results from Expert Delphi Consensus Survey on Treatment of Pulmonary Arterial Hypertension with Oral Prostacyclin Pathway Agents AQ
Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017 GL
Actelion : Befreiung von Publizitätspflichten zur Aufrechterhaltung der Kotierung GL
Actelion : Johnson & Johnson Completes Acquisition of Actelion GL
Actelion : Publication of Idorsia's prospectus relating to the listing of Idorsia Ltd on SIX Swiss Exchange PU
More press releases

News in other languages on Actelion

Après Bioverativ, Sanofi s'empare de la biotech belge Ablynx pour 3,9 mrd EUR
Après Bioverativ, Sanofi rachète la biotech belge Ablynx pour 3,9 mrd EUR
Avec Bioverativ, Sanofi devient un leader mondial dans l'hémophilie
GNW-News: Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
Actelion : Cancellation of publicly held Actelion shares and delisting from SIX Swiss Exchange as of November 7, 2017
More news

Company Profile

More about the company

Sector Bio Therapeutic Drugs

1st Jan change Capi.
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
-2.31% 103B
REGENERON PHARMACEUTICALS, INC. Stock Regeneron Pharmaceuticals, Inc.
+0.56% 95.28B
ARGENX SE Stock argenx SE
+1.69% 22.15B
BIONTECH SE Stock BioNTech SE
-17.37% 21.02B
GENMAB A/S Stock Genmab A/S
-9.30% 18.15B
WUXI APPTEC CO., LTD. Stock WuXi AppTec Co., Ltd.
-41.01% 16.74B
BEIGENE, LTD. Stock BeiGene, Ltd.
-14.85% 16.05B
NEUROCRINE BIOSCIENCES, INC. Stock Neurocrine Biosciences, Inc.
+3.21% 13.68B
SAREPTA THERAPEUTICS, INC. Stock Sarepta Therapeutics, Inc.
+33.54% 12.17B
Bio Therapeutic Drugs
  1. Stock Market
  2. Equities
  3. ATLN Stock